Individualized, discrete event, simulations provide insight into inter- and intra-subject variability of extended-release, drug products.

Theoretical biology & medical modelling

Volumn 9, Issue , 2012, Pages 39-

  Kim, Sean H J ^a   Jackson, Andre J ^b   Hur, Rim ^b   Hunt, C Anthony ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADULT; ARTICLE; BIOAVAILABILITY; COMPUTER PROGRAM; COMPUTER SIMULATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DRUG EFFECT; GASTROINTESTINAL TRACT; HUMAN; METABOLISM; RANDOMIZED CONTROLLED TRIAL; THERAPEUTIC EQUIVALENCE;

ADULT; BIOLOGICAL AVAILABILITY; COMPUTER SIMULATION; DELAYED-ACTION PREPARATIONS; GASTROINTESTINAL TRACT; HUMANS; PHARMACEUTICAL PREPARATIONS; SOFTWARE; THERAPEUTIC EQUIVALENCY;

EID: 84865540578     PISSN: None     EISSN: 17424682     Source Type: None    
DOI: 10.1186/1742-4682-9-39     Document Type: Article

References (0)